These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 15864218)

  • 1. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
    Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks.
    John S; Delles C; Jacobi J; Schlaich MP; Schneider M; Schmitz G; Schmieder RE
    J Am Coll Cardiol; 2001 Apr; 37(5):1351-8. PubMed ID: 11300446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
    Tran D; Lowy A; Howes JB; Howes LG
    Diabetes Obes Metab; 2005 May; 7(3):273-81. PubMed ID: 15811145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients.
    Perticone F; Ceravolo R; Maio R; Cloro C; Candigliota M; Scozzafava A; Mongiardo A; Mastroroberto P; Chello M; Mattioli PL
    Atherosclerosis; 2000 Oct; 152(2):511-8. PubMed ID: 10998481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study.
    John S; Schlaich M; Langenfeld M; Weihprecht H; Schmitz G; Weidinger G; Schmieder RE
    Circulation; 1998 Jul; 98(3):211-6. PubMed ID: 9697820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.
    Fichtlscherer S; Schmidt-Lucke C; Bojunga S; Rössig L; Heeschen C; Dimmeler S; Zeiher AM
    Eur Heart J; 2006 May; 27(10):1182-90. PubMed ID: 16621868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
    Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
    Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients.
    Taddei S; Versari D; Cipriano A; Ghiadoni L; Galetta F; Franzoni F; Magagna A; Virdis A; Salvetti A
    J Am Coll Cardiol; 2006 Aug; 48(3):508-15. PubMed ID: 16875977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels.
    Mercuro G; Zoncu S; Saiu F; Sarais C; Rosano GM
    Am J Cardiol; 2002 Oct; 90(7):747-50. PubMed ID: 12356389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
    Dogra GK; Watts GF; Chan DC; Stanton K
    Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells.
    Kimura M; Ueda K; Goto C; Jitsuiki D; Nishioka K; Umemura T; Noma K; Yoshizumi M; Chayama K; Higashi Y
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1403-10. PubMed ID: 17446439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide.
    Passauer J; Pistrosch F; Büssemaker E; Lässig G; Herbrig K; Gross P
    J Am Soc Nephrol; 2005 Apr; 16(4):959-65. PubMed ID: 15728785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia.
    Matsuo T; Iwade K; Hirata N; Yamashita M; Ikegami H; Tanaka N; Aosaki M; Kasanuki H
    Heart Vessels; 2005 Feb; 20(1):8-12. PubMed ID: 15700196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM; Unger P; Ghisdal L; Broeders N; Berkenboom G; Carpentier Y; Abramowicz D
    Transplantation; 2006 Sep; 82(6):771-8. PubMed ID: 17006324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia.
    Green D; O'Driscoll G; Rankin JM; Maiorana AJ; Taylor RR
    Clin Sci (Lond); 1998 Sep; 95(3):361-7. PubMed ID: 9730857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans.
    Nishioka K; Hidaka T; Nakamura S; Umemura T; Jitsuiki D; Soga J; Goto C; Chayama K; Yoshizumi M; Higashi Y
    Hypertens Res; 2007 Sep; 30(9):775-80. PubMed ID: 18037769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.
    Heitzer T; Rudolph V; Schwedhelm E; Karstens M; Sydow K; Ortak M; Tschentscher P; Meinertz T; Böger R; Baldus S
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1648-52. PubMed ID: 16675725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients.
    Sakabe K; Fukuda N; Wakayama K; Nada T; Shinohara H; Tamura Y
    Int J Cardiol; 2004 Mar; 94(1):111-7. PubMed ID: 14996484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease.
    Fichtlscherer S; Dimmeler S; Breuer S; Busse R; Zeiher AM; Fleming I
    Circulation; 2004 Jan; 109(2):178-83. PubMed ID: 14662709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.